Strategy Inc Director Executes Stock Options and Conducts Open Market Sale

Director Stock Option Exercise at $18.236 Per Share

The filing discloses that Jarrod M. Patten exercised 1,250 shares of director stock options on July 22, 2026, at an exercise price of $18.236 per share. According to the regulatory disclosure, these options vested on May 31, 2018, meaning they had been exercisable for a substantial period prior to the July 2026 transaction. The exercise represents a standard form of equity compensation realization for board members at public companies.

The remaining balance of director stock options held by Patten totals 40,000 shares. The filing provides detail on the vesting schedule of these remaining options, indicating that 2,500 shares vested on May 31, 2018, 12,500 shares vested on May 31, 2019, 12,500 shares vested on May 31, 2020, and 12,500 shares vested on May 31, 2021. This information suggests that all remaining options have already satisfied their vesting requirements and are currently exercisable by the reporting person.

Open Market Sale Concurrent with Option Exercise

On the same trading date of July 22, 2026, Patten sold 1,250 shares of Class A Common Stock at a price of $100 per share. This sale transaction occurred on the same day as the option exercise, representing a common strategy where insiders exercise options and immediately sell shares in the open market. The $100 sale price per share represents a significantly higher value than the $18.236 exercise price on the same securities, indicating a material gain on the transaction.

The open market sale transaction is coded as a standard market sale in the regulatory filing, with no special conditions or restrictions noted. This type of concurrent exercise-and-sale activity is regularly observed among corporate directors and officers managing their equity compensation and portfolio positions.

Beneficial Ownership Position Following Transactions

Following the July 22, 2026 transactions, Patten's direct beneficial ownership of Class A Common Stock stands at 28,406 shares. This figure reflects the acquisition of 1,250 shares through the option exercise and the simultaneous disposition of 1,250 shares through the open market sale, resulting in a net zero change in share count from these two transactions. The ending beneficial ownership position of 28,406 shares represents Patten's direct holdings in the most widely-held class of company equity.

In addition to Class A Common Stock, the filing documents that Patten holds preferred stock across multiple series. The disclosure indicates direct beneficial ownership of 10,000 shares of Series A Perpetual Strife Preferred Stock, 29,335 shares of Series A Perpetual Stretch Preferred Stock, and 5,000 shares of Series A Perpetual Stride Preferred Stock. These preferred holdings total 44,335 shares and are listed as held directly by the reporting person.

Director Status and Reporting Obligations

The filing identifies Patten as a director of Strategy Inc, a classification that subjects him to Section 16 insider reporting requirements under the Securities Exchange Act of 1934. Directors are required to file public disclosures of their securities transactions, creating transparency into equity holdings and trading activity by members of the board of directors. This reporting requirement applies to all trades in company securities regardless of the dollar amount or strategic rationale.

The Form 4 filing was signed by Allein Sabel, identified as attorney-in-fact for Patten, on July 23, 2026, one business day after the transaction date. This filing mechanism ensures that material changes in beneficial ownership by insiders are disclosed promptly to the investing public and the Securities and Exchange Commission.

Option Vesting History and Schedule Detail

The filing provides explicit detail regarding the vesting history of Patten's director stock options. The 1,250 shares that were exercised on July 22, 2026, had vested on May 31, 2018—more than eight years prior to the exercise date. This extended period between vesting and exercise is not uncommon among long-tenured board members who may accumulate exercisable options over extended timeframes.

The remaining 40,000 unexercised options are fully vested as of the filing date, with all vesting milestones having been satisfied by May 31, 2021. No unvested or contingent options are reported in this disclosure, indicating that all of Patten's director stock option grants have completed their vesting requirements. The vesting schedule detailed in the filing spans from May 31, 2018, through May 31, 2021, with consistent annual vesting increments of 12,500 shares in the intermediate years.

Exercise Price Dynamics and Market Value Differential

The exercise price of $18.236 per share on the director stock options reflects the stock price at the time of grant for these equity compensation awards. The subsequent sale at $100 per share represents a significant appreciation in the company's stock value between the grant date and the exercise date. While the filing does not provide explicit information regarding the grant date of these particular options, the vesting schedule indicates they were granted sufficiently in advance to begin vesting on May 31, 2018.

The material spread between the option exercise price and the open market sale price demonstrates the value creation inherent in the director compensation structure at Strategy Inc. This pricing differential is typical in equity compensation arrangements where options are granted at fair market value and subsequently exercised at a later date when company performance has potentially driven stock appreciation.

Transaction Coding and Compliance Methodology

The filing employs standard SEC transaction codes to classify the activities disclosed. The option exercise is coded as "M," representing a derivative security transaction that involves the grant of an option or similar right. The open market sale is coded as "S," representing a standard sale of securities. These coding conventions enable systematic tracking and analysis of insider transactions across all public companies.

The disclosure indicates that neither the option exercise nor the subsequent sale was executed pursuant to a Rule 10b5-1 trading plan, as evidenced by the absence of a checkbox indicating such a plan. Rule 10b5-1 plans are contractual arrangements that allow insiders to establish predetermined trading schedules in advance, providing affirmative defense against claims of trading on material nonpublic information. The absence of such a plan notation does not indicate any impropriety; rather, it reflects that these transactions were executed through standard market mechanisms.

Indirect Ownership Designations and Form Characterization

All securities reported in this filing are designated as directly owned by Patten, with no indirect beneficial ownership interests noted. This direct ownership classification indicates that Patten holds legal and beneficial title to the securities in his own name or in accounts under his direct control, rather than through intermediary entities or arrangements. The filing contains no disclosures regarding trusts, family member holdings, or other indirect ownership structures.

The Form 4 represents a single-person filing, as indicated by the checkbox for "Form filed by One Reporting Person." This classification confirms that only Patten is reporting in this disclosure and that no joint or group filing was required or executed. The individual filing structure is standard for director option exercises and routine insider transactions.

Strategic Considerations for Investor Analysis

The concurrent exercise and sale of shares on the same trading date may reflect various strategic considerations by the reporting director. Such transactions are commonly employed to capture the spread between option exercise prices and current market prices while maintaining a stable overall position in company equity. The fact that Patten exercised and sold identical quantities of shares suggests a deliberate portfolio management decision rather than a directive response to company performance or market conditions.

Investors analyzing insider trading activity typically focus on patterns of accumulation or disposition over time, rather than on individual transactions. A single exercise-and-sale transaction on a single date provides limited insight into overall insider confidence or concerns regarding company value. More meaningful patterns emerge when reviewing cumulative insider activity across multiple reporting persons and extended time periods.